Table 1.
Pre-KAS n=20,692 | Post-KAS n=8481 | P Value | |
---|---|---|---|
Median (IQR) age | 55 (44–63) | 52 (40–62) | <0.001 |
Pediatric (%) | 4.3 | 4.0 | 0.3 |
Female (%) | 39.1 | 40.6 | 0.02 |
Race/ethnicity (%) | <0.001 | ||
Black | 31.7 | 37.2 | |
Hispanic | 16.9 | 18.4 | |
All others | 51.3 | 44.4 | |
Final CPRA (%) | <0.01 | ||
0 | 58.7 | 53.9 | |
1–20 | 9.9 | 9.6 | |
21–80 | 16.6 | 14.2 | |
81–97 | 11.5 | 7.2 | |
98 | 0.9 | 1.2 | |
99 | 1.3 | 3.6 | |
100 | 1.0 | 10.3 | |
Blood type (%) | <0.001 | ||
O | 45.7 | 46.0 | |
A | 36.5 | 34.7 | |
B | 12.8 | 13.2 | |
AB | 5.0 | 6.2 | |
Share type (%) | <0.001 | ||
Local | 78.6 | 68.4 | |
Regional | 8.8 | 12.5 | |
National | 12.7 | 19.1 | |
Zero-mismatch (%) | 8.5 | 4.5 | <0.001 |
Median (IQR) CIT* | 15.8 (10.7–21.8) | 16.4 (11.8–23.2) | <0.001 |
After the implementation of KAS, DDKT recipients were more likely to be younger, to be black or Hispanic, to have a CPRA of 100, and to receive a kidney transplantation through a regional or national share (all P<0.001).